BETHESDA, Md., Oct. 8, 2018 /PRNewswire-PRWeb/ -- The Parenteral Drug Association (PDA) announced the formation of the
The Pacific Northwest Chapter will hold a kickoff and welcome reception on November 8, 2018 from 6:00 – 8:30 pm at Aptevo Therapeutics in Seattle, Wash. This inaugural event will be attended by Richard Johnson, President and CEO of PDA, who will discuss the PDA's organizational structure, mission, and role in guiding parenteral drug development. The event will also feature a keynote presentation by local FDA compliance officers, Maria Kelly-Doggett and William Millar, who will be discussing lifecycle management of parenteral drugs. Officers Kelly-Doggett and Millar will also be fielding questions and providing information on local FDA resources.
The following experts will serve as the volunteer officers for the PDA Pacific Northwest Chapter: President: Lisa Rutter, Partner Therapeutics President-Elect: Brian Hawkins, BioLife Solutions, Inc. Secretary: Irene Braginskaya, Nohla Therapeutics Treasurer: Anethra Wilson, Partner Therapeutics Members At Large: Alireza Abazari, BioLife Solutions; Julia Hart, Aptevo Therapeutics
About PDA – Connecting People, Science and Regulation® The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of over 10,500 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.
SOURCE Parenteral Drug Association
Subscribe to our Free Newsletters!